Boehringer Ingelheim Venture Fund
Thesis
Corporate VC backing seed/Series A first-in-class therapeutics across oncology, regen med, immunology, anti-infectives and digital health.
Sectors
BiotechHealthcare/MedtechLife SciencesDeep Tech/Hard ScienceAI/ML
Fund
- Current fund
- Boehringer Ingelheim Venture Fund (evergreen) · 2010 · $EUR 350M
- AUM
- $EUR 350M